Inovio Pharmaceuticals (INO) Current Assets (2016 - 2025)
Historic Current Assets for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $55.2 million.
- Inovio Pharmaceuticals' Current Assets fell 3955.14% to $55.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.2 million, marking a year-over-year decrease of 3955.14%. This contributed to the annual value of $97.8 million for FY2024, which is 3610.6% down from last year.
- Latest data reveals that Inovio Pharmaceuticals reported Current Assets of $55.2 million as of Q3 2025, which was down 3955.14% from $52.7 million recorded in Q2 2025.
- In the past 5 years, Inovio Pharmaceuticals' Current Assets registered a high of $588.4 million during Q1 2021, and its lowest value of $52.7 million during Q2 2025.
- Over the past 5 years, Inovio Pharmaceuticals' median Current Assets value was $203.3 million (recorded in 2023), while the average stood at $258.5 million.
- As far as peak fluctuations go, Inovio Pharmaceuticals' Current Assets soared by 11355.42% in 2021, and later crashed by 5517.47% in 2025.
- Inovio Pharmaceuticals' Current Assets (Quarter) stood at $448.4 million in 2021, then decreased by 29.7% to $315.2 million in 2022, then crashed by 51.43% to $153.1 million in 2023, then plummeted by 36.11% to $97.8 million in 2024, then crashed by 43.6% to $55.2 million in 2025.
- Its Current Assets was $55.2 million in Q3 2025, compared to $52.7 million in Q2 2025 and $71.9 million in Q1 2025.